Revium Rx (RVRC) Total Current Liabilities (2024 - 2025)
Revium Rx's (RVRC) quarterly Total Current Liabilities came in at $1.4 million in Q4 2025, up 137.67% year-on-year from $576000.0 in Q4 2024, and up 137.67% quarter-over-quarter from $576000.0 in Q4 2024.
Revium Rx (RVRC) Total Current Liabilities (2024 - 2025) Analysis & Trends
Revium Rx has disclosed Total Current Liabilities across 2 years of filings, most recently posting $1.4 million for Q4 2025.
- Total Current Liabilities for Q4 2025 came in at $1.4 million, up 137.67% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (up 137.67% YoY), and the FY2025 annual result was $1.4 million, up 137.67% from the prior year.
- Total Current Liabilities came in at $1.4 million for Q4 2025 at Revium Rx, up from $576000.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.4 million in Q4 2025 to a low of $576000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 1.70 Bn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 1.55 Bn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 135.74 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | 414.48 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 154.97 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 113.60 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 219.96 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 601.30 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 483.05 Mn |
| 10 | Revium Rx | - | - | - | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 576,000.00 |